Cortexin in the complex treatment of post stroke epilepsy
Comparison in people · 2010
- What was studied
- 46 patients with post-stroke epilepsy; 29 adjunctive Cortexin, 17 basic treatment
- Main finding
- The report describes improved clinical effects and EEG findings alongside anti-seizure treatment.
Reported findings and study design
46 patients with post-stroke epilepsy: Cortexin add-on 29 versus basic care 17. Background Depakine-chrono averaged 750 mg/day; Cortexin 10 mg IM for 15 days.
Population or model 46 patients with post-stroke epilepsy; 29 adjunctive Cortexin, 17 basic treatment
Dose, route and schedule
Cortexin: 10 mg intramuscularly during a 15-day course, added to vascular drugs and Depakine Chrono (mean 750 mg/day). Cortexin administration frequency is not specified in the indexed abstract. Outcomes concern combination treatment.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Clinical and EEG effects | Add-on group favored | Seizure counts and numerical EEG effect sizes not given |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Concurrent treatment prevents attribution to Cortexin alone.
- The abstract does not establish sustained seizure freedom, prevention of epilepsy or randomized allocation.
Source details
Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.
Abstract reviewed
Sources checked
Citation
Gafurov BG, Gafurov ShB. Cortexin in the complex treatment of post stroke epilepsy Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 20873481